Memorial Sloan Kettering Suffolk- Commack (Limited Protocol Activities) is a clinical research site located in Commack, New York, United States 11725.
Crixeo Health Trust Score: 74/100 (FAIR). This profile has not yet been claimed by the site owner.
Memorial Sloan Kettering Suffolk- Commack (Limited Protocol Activities) has participated in 17 clinical trials with 16 currently active.
Therapeutic areas: Malignant Pleural Mesothelioma, Oropharyngeal Carcinoma, Chemotherapy-induced Peripheral Neuropathy.
Sponsors: Memorial Sloan Kettering Cancer Center, Dana-Farber Cancer Institute.
Trust Score: 74/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Memorial Sloan Kettering Suffolk- Commack (Limited Protocol Activities) has a Crixeo Trust Score of 74/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Memorial Sloan Kettering Suffolk- Commack (Limited Protocol Activities) has 17 clinical trials on record, with 16 currently active. Their work covers Malignant Pleural Mesothelioma, Oropharyngeal Carcinoma, Chemotherapy-induced Peripheral Neuropathy.
Memorial Sloan Kettering Suffolk- Commack (Limited Protocol Activities) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.